Pharmacists completing the Pediatric Pharmacy Residency Program will be able to provide proficient, confident, and compassionate direct patient care in multiple pediatric patient environments.

Practitioners will be accountable for promoting safe and effective drug usage and achieving optimal drug therapy outcomes as vital members of the health care team. Also, because the University of Maryland School of Pharmacy jointly manages this program with the University of Maryland Hospital for Children (UMHC), the pharmacist will be able to exercise skill in educating other health care professionals, patients, and the community on drug therapy-related topics, and will possess skill in conducting pharmacy practice-related research.

As part of its accreditation by the American Society of Health-System Pharmacists (ASHP), this program is committed to the following general purpose:

Postgraduate Year 2 (PGY2) pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and Postgraduate Year 1 (PGY1) pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Additionally, our program adheres to the Goals and Objectives for a Post-Graduate Year Two Program in Pediatric Pharmacy set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.

Purpose:

PGY-2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in pediatric pharmacy practice. PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete our accredited PGY-2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with pediatric board certification.

Required Learning Experiences:

  • General Pediatrics
  • Pediatric Sub-specialties (GI and Heme-Onc)
  • Neonatal Intensive Care Unit
  • Pediatric Intensive Care Unit
  • Pediatric Toxicology - Maryland Poison Center
  • Pediatric Ambulatory Clinic (longitudinal)
  • Practice Management Experience (longitudinal)

Elective Rotation Opportunities:

Each resident will have the opportunity to customize his or her residency experience with the program director.

Other Learning Experiences:

In addition to the pharmacy practice experiences outlined above, the resident will also have the opportunity to participate in the following longitudinal learning experiences:

Staffing:

  • The resident will work in the pediatric pharmacy satellite every third weekend on Saturday and Sunday
  • The resident will cover the PILL pager and clinical consult service for one week every 6 weeks

Teaching:

  • The resident is required to complete approximately 40 hours of teaching each semester.
  • Residents are appointed as clinical instructors at the University of Maryland School of Pharmacy.
  • One hour of teaching in the Pediatric Elective is required.
  • Other teaching activities may include didactic lectures, small group discussions, and skills laboratories.
  • A teaching certificate program is available for interested residents.

Scholarship Experiences:

The resident is required to complete the following scholarship activities:

  • Conduct one longitudinal research project
  • A final manuscript of the research project must be prepared in a publishably format
  • Presentation of interim or final results of research project at the Pediatric Pharmacy Association Annual meeting
  • Complete one medication utilization evaluation (MUE) or management project

Professional Development Experiences
The resident will also participate in the following professional development activities:

  • Pharmacotherapy Rounds
  • UMMC Pediatric P&T Committee participation
  • Professional Development Series
  • Community Service Activity
  • Case Conference presentation
  • Journal Club presentation
  • Pediatric journal scan presentation

Participation in Pharmacotherapy Rounds, Professional Development lecture series, and staffing responsibilities is a requirement of all University of Maryland residents. For more information about these specific activities, please visit the Residency & Fellowship Requirements webpage.

About the University of Maryland Hospital for Children (UMHC):

In providing the best possible care for children of all ages, the University of Maryland Hospital for Children (UMHC) takes the slogan "Children Are Our Future" very seriously. Recognized statewide and regionally as a center of excellence for children with critical illnesses and complex, chronic conditions, UMHC combines state-of-the-art medicine with family-centered care.

There are 145 licensed beds caring for over 20 specialties, with a level IV NICU with 52 beds and a 19-bed PICU/PCICU. There are approximately 4,500 admissions annually, including 1,000 admissions to the PICU/IMC. Our services range from primary care to highly specialized treatment programs that attract patients from the entire mid-Atlantic region.

Number of Available Positions: 1

Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (requirement waived if completed a pass/fail curriculum). The Doctor of Pharmacy (PharmD) degree and Maryland Pharmacy licensure are required. Residents must complete a ASHP-accredited PGY1 residency prior to starting.

Application Process:

The application deadline is January 1.

Applications for this program will only be accepted through PhORCAS. Reference writers should use the standard reference template in PhORCAS.

Application requirements:

  • Letter of intent
  • Curriculum vitae
  • Letters of recommendation (3)
  • Official transcripts

International students and permanent residents should contact umresfelprogram@rx.umaryland.edu before applying.

Residents who match to this program will be required to come to Baltimore in advance of the July 1st start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.

Program Director:

Kristine A. Parbuoni, PharmD, BCPPS
Associate Professor and Director of OSCE Programs
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
20 N. Pine Street
Baltimore, MD 21201
Phone: (410) 706-3629
Email: kparbuoni@rx.umaryland.edu